"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 2002/026747 A1,159-280-120-444-390,2002-04-04,2002,GB 0104317 W,2001-09-27,GB 0023610 A,2000-09-27,"DIHYDROIMIDAZO[2,1-B]THIAZOLE AND DIHYDRO-5H-THIAZOLO[3,2-A]PYRIMIDINE DERIVATIVES WITH 5-HT RECEPTOR AFFINITY","The present invention relates to certain novel substituted dihydroimidazo[2,1-b]thiazole and dihydro-5H-thiazolo[3,2-a]pyrimidine compounds of Formula (I) which have affinity for 5-HT1A receptors and which inhibit neuronal reuptake of 5-hydroxytryptamine and/or noradrenaline, to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, obsessive-compulsive behaviour, panic attacks, social phobias, eating disorders such as bulimia, anorexia, snacking and binge eating, non-insulin dependent diabetes mellitus, hyperglycaemia, hyperlipidaemia, stress, as an aid to smoking cessation and in the treatment and/or prophylaxis of seizures, neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as stroke, brain trauma, cerebral ischaemia, head injuries and haemorrhage.",KNOLL GMBH;;BROUGH PAUL;;WATTS JOHN PAUL;;COCKROFT VICTOR;;KERRIGAN FRANK;;DOYLE KEVIN JAMES,BROUGH PAUL;;WATTS JOHN PAUL;;COCKROFT VICTOR;;KERRIGAN FRANK;;DOYLE KEVIN JAMES,,https://lens.org/159-280-120-444-390,Patent Application,yes,4,8,3,3,0,C07D513/04;;A61P25/24,A61P25/24;;C07D513/04,,1,1,010-012-260-584-454,10.1021/jm00292a023;;5165571,"SHARPE C J ET AL: ""PHENACYLTHIOIMIDAZOLINES AND 3-ARYL-5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLES WITH ANTIDEPRESSANT ACTIVITY"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 14, no. 10, 1971, pages 977 - 982, XP002015395, ISSN: 0022-2623",PENDING
2,AU,A,AU 2001/090126 A,102-374-281-400-240,2002-04-08,2002,AU 2001/090126 A,2001-09-27,GB 0023610 A;;GB 0104317 W,2000-09-27,"Dihydroimidazo(2,1-b)thiazole and dihydro-5h-thiazolo(3,2-a)pyrimidine derivatives with 5-ht receptor affinity",,KNOLL GMBH,BROUGH PAUL;;WATTS JOHN PAUL;;COCKROFT VICTOR;;KERRIGAN FRANK;;DOYLE KEVIN JAMES,,https://lens.org/102-374-281-400-240,Patent Application,no,0,0,3,3,0,A61P25/24;;C07D513/04,A61P25/24;;C07D513/04,,0,0,,,,PENDING
